Journal of Infectious Diseases and Medicine

Precision medicine has revolutionized healthcare by tailoring treatments to individual patients' unique characteristics. While initially applied to cancer and genetic disorders, this article explores the current trends and future prospects of precision medicine in the context of infectious diseases. We examine how genomics, omics technologies, and advanced diagnostics are reshaping infectious disease diagnosis and treatment. Through this review, we aim to shed light on the potential of precision medicine to transform the field, enhance therapeutic outcomes, and mitigate the impact of infectious diseases on public health.

Climate change is altering the distribution and behavior of disease vectors, amplifying the transmission of vector-borne infectious diseases worldwide. This multidisciplinary analysis explores the multifaceted effects of climate change on the global spread of these diseases, incorporating ecological, epidemiological, and public health perspectives. We assess the changing dynamics of vector habitats, disease transmission patterns, and the implications for human and animal populations. Our findings underscore the urgent need for adaptive strategies and international cooperation to mitigate the expanding threat of vector-borne diseases in a warming world.

The emergence of Antimicrobial Resistance (AMR) poses a critical threat to global public health. Antibiotic stewardship programs have become essential tools in combating this growing crisis. This article explores the innovations and challenges associated with antibiotic stewardship in the context of AMR. It delves into the latest advancements in stewardship strategies, the role of technology, and the socio-economic factors influencing antibiotic use. By critically examining these aspects, we aim to provide insights that will guide efforts to optimize antibiotic use, preserve these life-saving drugs, and mitigate the consequences of AMR.

Drug-Resistant Tuberculosis (DR-TB) poses a formidable challenge to global public health. This comprehensive review examines the current state of knowledge regarding DR-TB and explores emerging strategies for its prevention and treatment. We discuss the genetic basis of drug resistance, the role of diagnostic tools, novel therapeutic approaches, and the importance of public health interventions. By highlighting recent developments and ongoing research, this review aims to inform policymakers and healthcare professionals on effective strategies to combat the growing threat of DR-TB.